Tag:
H5N1
Latest Headlines
Latest Headlines
Inovio makes steps towards a universal flu vax
Inovio Pharmaceuticals thinks it is a step closer to the prize with a universal avian flu vax that has triggered protective responses against 6 h5N1 virus in one go in a Phase I clinical trial.
Bird flu vaccine hits the clinic
Novavax saw a climb in its share value on the announcement that it has started enrollment of a Phase I clinical trial of its A/H5N1 vaccine to prevent bird flu.
Bioterrorism concerns vanquished, Nature publishes bird flu paper
After U.S. government efforts to restrict publication of research involved in building variations of the H5N1 bird flu virus, the journal Nature has published the first of two of the controversial papers involved in the dust-up, Reuters reports.
Scientists balk as U.S. gov't pushes limits to bird flu discourse
Scientists are crying foul about U.S. government efforts to seek publication restrictions on research involved in building variations of the H5N1 bird flu virus. Others are OK with the move,...
Fearing weaponized H5N1, U.S. security officials move to censor research
A panel of U.S. biosecurity officials is asking investigators to keep some of their new research on bird flu under wraps, fearing that terrorists could use the information on the infectious disease
New strain of H5N1 lacks vax protection
Scientists have discovered a mutant strain of the bird flu, which has been observed in China and Vietnam, and the variant is different enough that current vaccines won't protect against it. So far,
Vaxart starts Ph1 oral vax trial
San Francisco-based Vaxart has started dosing patients in its first Phase I trial using its oral vaccine platform. The study uses an H5N1 flu vaccine, but the platform, if effective, could be used
Intercell scrambles after vax patch flunks PhII
Startled by the unexpected failure of a mid-stage trial of its vaccine adjuvant patch, Intercell AG is changing up the vaccine it used in the study along with the hemagglutinin inhibition assay used
Novavax VLP vax works against 1918 Spanish flu
Novavax says that a virus-like particle vaccine it developed was successful in guarding against both the deadly 1918 Spanish flu strain as well as an H5N1 strain in a preclinical study. Researchers
Poland investigates deaths of homeless in vaccine trial
Polish officials are investigating the deaths of a number of homeless people who were recruited to take part in a clinical trial of a new avian flu vaccine trial. According to some of the officials,
